Telehealth Integration Does Not Prevent Quality of Life Decline in Palliative Care

Digital Integration in Specialized End-of-Life Care

The global requirement for palliative services is rising sharply as populations age, with an estimated 4.4 million people in Europe alone requiring such care annually [1, 2]. To address geographical barriers and limited clinical resources, healthcare systems have increasingly turned to telehealth as a means of delivering community-based and home-based care [3, 4]. Meta-analytic data involving 2,324 patients with chronic heart failure show that remote interventions significantly reduce hospitalization rates (OR 0.60; 95% CI: 0.41 to 0.86; p = 0.006) and improve quality of life scores [5]. However, evidence remains inconsistent across broader populations; for example, a randomized trial of 182 patients in Denmark found no significant differences in health-related quality of life or symptom burden when comparing telehealth-augmented care to standard specialized palliative care [1, 6]. These discrepancies raise significant questions regarding the maintenance of the patient-provider relationship and the efficacy of remote symptom monitoring [2]. A recent randomized controlled trial now provides data on how these digital tools perform when integrated into existing specialized palliative frameworks.

Trial Design and Patient Monitoring Protocols

Rigorous longitudinal monitoring formed the backbone of this randomized controlled trial, which followed 182 patients referred to specialized palliative care (SPC) in Denmark. Participants were monitored for up to 26 weeks to evaluate the impact of digital health integration on the terminal disease trajectory. The researchers randomized the cohort into two arms: the control group (CG), receiving routine specialized palliative care, and the intervention group (TPG), receiving routine specialized palliative care plus telepalliative care (TPC). This design allowed for a direct comparison between standard clinical practice and a model augmented by remote digital support, aiming to determine if frequent virtual touchpoints could improve patient outcomes. To capture the nuances of the patient experience, the researchers employed several validated instruments at high frequencies. Health-related quality of life (HRQoL) and symptom burden were assessed weekly using the European Organization for Research and Treatment of Cancer Quality of life Questionnaire–Core 15–Palliative Care (EORTC QLQ-C15-PAL). This tool is a truncated version of a standard cancer quality-of-life instrument, specifically refined to reduce respondent burden while measuring physical, emotional, and social functioning in patients with life-limiting illness. Additionally, HRQoL and perceived health were evaluated at weeks 1 and 4 using the EuroQol Five-Dimension Five-Level Questionnaire (EQ-5D-5L), a standardized instrument that measures health status across five dimensions including mobility, self-care, and usual activities. Perceived health was further quantified at weeks 1 and 4 using the Visual Analog Scale (VAS), a self-rating tool for health status that allows patients to mark their current health on a scale from 0 to 100, providing a subjective snapshot of their overall well-being. Beyond physical symptoms, the trial focused on the psychological state of the participants. The patients’ sense of security was assessed twice weekly using a Likert scale, a psychometric rating scale used to measure the intensity of attitudes or feelings, such as the degree to which a patient feels safe and supported in their home environment. By utilizing these frequent touchpoints, the study aimed to identify whether the addition of telepalliative care could mitigate the expected decline in quality of life and sense of security as patients progressed through their illness.

Symptom Trajectories and Quality of Life Outcomes

The researchers initially hypothesized that the Telepal program would improve health-related quality of life (HRQoL) and the patients' sense of security when compared with standard specialized palliative care (SPC). However, the longitudinal data collected over the 26 week study period did not support this expectation. Instead, the researchers observed that health-related quality of life, symptom burden, and sense of security worsened over time in both the intervention and control groups. This downward trajectory reflects the expected clinical progression of patients requiring specialized palliative services, and the digital intervention did not statistically alter this course. When comparing the two cohorts, the analysis revealed no significant group differences in health-related quality of life, symptom burden, or sense of security. These findings suggest that the addition of a digital interface did not provide a measurable clinical advantage over traditional specialized palliative care protocols for these specific endpoints. While the intervention group (TPG) showed a more stable trajectory in their perceived health on the Visual Analog Scale compared to the decline seen in the control group, this did not translate into a broader improvement in the primary metrics of patient well-being or clinical stability. A specific finding of clinical interest was that the telepalliative care group reported consistently higher pain levels than the control group throughout the study. While the study did not identify a definitive cause for this difference, it underscores the challenges of managing complex physical symptoms through remote monitoring platforms, where the lack of physical examination may limit the clinician's ability to titrate analgesics effectively. Despite the lack of improvement in symptom burden or security, the researchers noted that the digital program might still function as a complementary component of care for patients who face significant physical or geographical barriers to attending in-person clinical visits.

Stability of Perceived Health and Clinical Utility

Addressing the massive scale of end-of-life care needs remains a significant challenge for healthcare systems, as an estimated 4.4 million people in Europe require palliative care annually, a figure that is projected to increase as the population ages. To address this demand, the Telepal program was developed to provide individualized palliative care aiming to improve health-related quality of life (HRQoL) and enhance access to health care professionals. While the primary outcomes of the trial did not show the expected improvements in symptom burden or sense of security, a divergence was noted in how patients viewed their overall health status. Specifically, perceived health declined in the control group but remained stable in the telepalliative care group, as measured by the EuroQol Five-Dimension Five-Level Questionnaire and its associated Visual Analog Scale (a tool where patients rate their current health state on a scale from 0 to 100). These findings indicate that while the Telepal intervention did not prevent the natural decline in health-related quality of life or sense of security, it may still hold value within a multimodal care plan. The researchers suggested that telepalliative care may serve as a complementary component of palliative care, particularly for those patients who face significant physical or geographical barriers to attending in-person clinical visits. By maintaining a consistent link to the care team, the program provides a mechanism for individualized support that traditional models might miss for homebound patients. Although the intervention group reported higher pain levels, the stability in perceived health scores indicates that the digital platform offers a unique clinical utility that warrants further investigation into which specific patient subgroups benefit most from remote monitoring. For the practicing clinician, these results suggest that while telepalliative care is not a replacement for intensive in-person specialized care, it may provide a stabilizing psychological effect on a patient's perception of their own health status during the terminal phase of illness.

References

1. Sigaard JVA, Spindler H, Joensen EDR, Ritterbusch ESB, Rasmussen MK, Dinesen B. Using Telehealth in End-of-Life Palliative Care: A Multimethod Randomized Controlled Trial.. Journal of palliative medicine. 2026. doi:10.1177/10966218261444643

2. Krieckemans L, Cavolo A, Casaer M, Gastmans C. Telehealth in palliative care settings: A systematic review of argument-based ethics literature.. Palliative medicine. 2025. doi:10.1177/02692163251360115

3. Haroen H, Juniarti N, Sari CWM, et al. Integrating Telehealth into Community-Based Palliative Care: A Systematic Review.. Journal of multidisciplinary healthcare. 2025. doi:10.2147/JMDH.S555226

4. Ghazal KY, Beniwal SS, Dhingra A. Assessing Telehealth in Palliative Care: A Systematic Review of the Effectiveness and Challenges in Rural and Underserved Areas.. Cureus. 2024. doi:10.7759/cureus.68275

5. Sebastian SA, Shah Y, Arsene C. Effectiveness of integrated palliative care telehealth intervention in patients with chronic heart failure: A systematic review and meta-analysis of randomized controlled trials.. Current problems in cardiology. 2024. doi:10.1016/j.cpcardiol.2024.102685

6. Chen Y, Qiao C, Zhang X, Li W, Yang H. The Effect of Tele-palliative Care on Patient and Caregiver Outcomes: A Systematic Review.. The American journal of hospice & palliative care. 2023. doi:10.1177/10499091221123566